Press Releases
Read about recent product innovations, annoucements, and company news across all of Legrand.
Kenall and Visa Reach Settlement | Indigo-Clean | Legrand
Read about the settlement reached by Kenall and Visa Lighting in 2020 on disinfecting lighting products using Vital Vio (Vyv) technology. Learn more.
Holy Family Memorial Fights Bacteria With Lighting | Legrand
Learn how Holy Family Memorial Medical Center installed bacterial fighting lighting fixtures in their operating room and saw great results. Learn more.
Independent University Study Validates Indigo-Clean® Kills SARS-CoV-2, Influenza-A
Kenall announced that the University of Tennessee has successfully confirmed the ground-breaking research performed by Mt. Sinai that shows Indigo-Clean® light disinfection technology inactivates SARS-CoV-2 and influenza A viruses.
Study finds Indigo-Clean Light Technology Effectively and Safely Kills SARS-CoV-2 and Influenza A Viruses
Legrand Announces Publication of Research Study Demonstrating Indigo-Clean Light Technology Effectively and Safely Kills SARS-CoV-2 and Influenza A Viruses
Hospital Achieves 73 Percent Reduction in SSIs | Legrand
Learn how Maury Regional Health Center was able to achieve a 73% reduction in SSIs with Indigo-Clean according to a clinical, peer reviewed study. Learn more.
Award-Winning Technology Licensed for US and CA | Legrand
Read the press release annoucing the licensing of the University of Strathclyde's award-winning technology for use in Indigo-Clean in North America. Learn more.
Indigo-Clean Makes ERCI 2016 Top 10 | Indigo-Clean | Legrand
Indigo-Clean EX made the ECRI Institute's 2016 Top 10 Hospital C-Suite Watch List for tools that leaders should consider in improvement planning. Learn more.
Kenall Files Lawsuits In NY and DE | Indigo-Clean | Legrand
Learn about the lawsuits that Kenall filed against ClearVu Lighting and NewStar Lighting in the Federal Courts of New York and Delware. Learn more.
Indigo-Clean® Eclipses Dated UV Lighting with New Upper Air Disinfection Claim
Indigo-Clean -- already proven to safely kill SARS-CoV-2 and other pathogens -- is offering a welcome and extremely effective disinfection alternative to UV: 405nm visible light.
Kenall and Visa Reach Settlement | Indigo-Clean | Legrand
Read about the settlement reached by Kenall and Visa Lighting in 2020 on disinfecting lighting products using Vital Vio (Vyv) technology. Learn more.
Kenall Settles Clear-Vu Litigation | Indigo-Clean | Legrand
Learn about the Kenall settlement of the ClearVu ligitation filed in 2017, including the resolution to which both parties agreed. Learn more.
Spring Valley Hospital Installs Indigo-Clean | Legrand
Learn why the second Valley Health System hospital, Spring Valley Hospital, installed Indigo-Clean EX in their hybrid cardiac operating suite Learn more.
First Two Midwest Hospitals Test Indigo-Clean | Legrand
Two Midwestern hospitals are the first to join a program that helps healthcare facilities evaluate the performance of Indigo-Clean technology. Learn more.
Henderson Hospital Installs Indigo Clean in OSC | Legrand
Learn why Henderson Hospital installed bacteria fighting operating room fixtures in their new outpatient surgical center in 2018. Learn more.
ASC Spartanburg Installs a First | Indigo-Clean | Legrand
Learn how ASC Spartanburg was the first surgery center in South Carolina to combat bacteria in their operating rooms by upgrading their lighting. Learn more.
New Light Fixtures Reduce Bacteria Levels in TN OR | Legrand
Learn about how new operating room light fixtures proved highly effective in reducing bacteria at Maury Regional Medical Center. Learn more.
Indigo-Clean Product Announcement | Indigo-Clean | Legrand
Read the press release about when Indigo-Clean first announced that its lighting technology was commercially available in the U.S. and Canada. Learn more.
Indigo-Clean Wins At 2016 Sapphire Awards Gala | Legrand
Learn how Indigo-Clean's innovative lighting disinfection solution wins the Specialty SSL Design Category at the Sapphire Awards Gala in 2016. Read more.